que se leu este artigo
array:25 [ "pii" => "S0870255120302043" "issn" => "08702551" "doi" => "10.1016/j.repc.2020.05.003" "estado" => "S300" "fechaPublicacion" => "2020-05-01" "aid" => "1542" "copyright" => "Sociedade Portuguesa de Cardiologia" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "dis" "cita" => "Rev Port Cardiol. 2020;39:277-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "en" => array:20 [ "pii" => "S2174204920302282" "issn" => "21742049" "doi" => "10.1016/j.repce.2020.10.009" "estado" => "S300" "fechaPublicacion" => "2020-05-01" "aid" => "1542" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "dis" "cita" => "Rev Port Cardiol. 2020;39:277-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial comment</span>" "titulo" => "Metalloproteinases as a prognostic marker in ST-elevation myocardial infarction" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "277" "paginaFinal" => "278" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Metaloproteinases como marcador prognóstico de STEMI" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jorge Mimoso" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Jorge" "apellidos" => "Mimoso" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0870255120302043" "doi" => "10.1016/j.repc.2020.05.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255120302043?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204920302282?idApp=UINPBA00004E" "url" => "/21742049/0000003900000005/v2_202011130957/S2174204920302282/v2_202011130957/en/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S0870255120302067" "issn" => "08702551" "doi" => "10.1016/j.repc.2019.12.006" "estado" => "S300" "fechaPublicacion" => "2020-05-01" "aid" => "1544" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Rev Port Cardiol. 2020;39:279-89" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>" "titulo" => "Chagas cardiomyopathy and heart failure: From epidemiology to treatment" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "279" "paginaFinal" => "289" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Cardiopatia chagásica e insuficiência cardíaca: da epidemiologia ao tratamento" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1034 "Ancho" => 1074 "Tamanyo" => 86404 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Chest X-ray showing increased cardiac area of a patient with Chagas cardiomyopathy.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Érico Santos, Luiz Menezes Falcão" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Érico" "apellidos" => "Santos" ] 1 => array:2 [ "nombre" => "Luiz" "apellidos" => "Menezes Falcão" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204920302294" "doi" => "10.1016/j.repce.2020.10.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204920302294?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255120302067?idApp=UINPBA00004E" "url" => "/08702551/0000003900000005/v2_202006270656/S0870255120302067/v2_202006270656/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S0870255120302079" "issn" => "08702551" "doi" => "10.1016/j.repc.2019.09.011" "estado" => "S300" "fechaPublicacion" => "2020-05-01" "aid" => "1545" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Cardiol. 2020;39:267-76" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: A two-year prospective study" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "267" "paginaFinal" => "276" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Valor prognóstico da elevação das metaloproteinases de matriz 9 nos doentes submetidos a intervenção coronária percutânea primária por enfarte do miocárdio com supradesnivelamento do segmento ST: estudo prospetivo a dois anos" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1094 "Ancho" => 1505 "Tamanyo" => 90659 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Kaplan-Meier analysis showing two-year cardiovascular mortality according to matrix metalloproteinase-9 level. MMP-9 cut-off: 12.92 pg/ml. MMP: matrix metalloproteinase.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mustafa Umut Somuncu, Hamdi Pusuroglu, Huseyin Karakurt, İsmail Bolat, Seda Tukenmez Karakurt, Ali Riza Demir, Nilgun Isıksacan, Ozgur Akgul, Ozgur Surgit" "autores" => array:9 [ 0 => array:2 [ "nombre" => "Mustafa Umut" "apellidos" => "Somuncu" ] 1 => array:2 [ "nombre" => "Hamdi" "apellidos" => "Pusuroglu" ] 2 => array:2 [ "nombre" => "Huseyin" "apellidos" => "Karakurt" ] 3 => array:2 [ "nombre" => "İsmail" "apellidos" => "Bolat" ] 4 => array:2 [ "nombre" => "Seda Tukenmez" "apellidos" => "Karakurt" ] 5 => array:2 [ "nombre" => "Ali Riza" "apellidos" => "Demir" ] 6 => array:2 [ "nombre" => "Nilgun" "apellidos" => "Isıksacan" ] 7 => array:2 [ "nombre" => "Ozgur" "apellidos" => "Akgul" ] 8 => array:2 [ "nombre" => "Ozgur" "apellidos" => "Surgit" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204920302270" "doi" => "10.1016/j.repce.2020.10.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204920302270?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255120302079?idApp=UINPBA00004E" "url" => "/08702551/0000003900000005/v2_202006270656/S0870255120302079/v2_202006270656/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial comment</span>" "titulo" => "Metalloproteinases as a prognostic marker in ST-elevation myocardial infarction" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "277" "paginaFinal" => "278" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Jorge Mimoso" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Jorge" "apellidos" => "Mimoso" "email" => array:1 [ 0 => "vmimoso@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Serviço de Cardiologia, Centro Hospitalar e Universitário do Algarve, Faro, Portugal" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Metaloproteinases como marcador prognóstico de STEMI" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Patients with acute coronary syndromes are a heterogeneous population, with different levels of severity and various predictors of mortality. Due to interactions between the various risk factors, scores have been created in order to identify populations at greater risk.<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In addition to clinical markers, biochemical markers such as elevated troponin T and C-reactive protein levels are strongly related to the long-term risk of death from cardiac causes.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Matrix metalloproteinases (MMPs) are enzymes involved in extracellular matrix remodeling and leukocyte recruitment to sites of inflammation, and act as important inflammatory modulators. MMP-9 plays a key role in the progression of atherosclerosis and vulnerability to plaque rupture,<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">4</span></a> and its plasma levels increase in patients with acute myocardial infarction. However, available data on the specific impact of baseline plasma MMP-9 levels and their utility as a prognostic marker in coronary artery disease are limited and at times conflicting.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">5,6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">In this issue of the <span class="elsevierStyleItalic">Journal</span>, Somuncu et al.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">7</span></a> present a study aiming to assess the clinical significance of MMP-9 in predicting two-year adverse cardiovascular events in patients who underwent primary percutaneous coronary intervention (PCI) after ST-elevation myocardial infarction (STEMI).</p><p id="par0025" class="elsevierStylePara elsevierViewall">In this single-center prospective study, blood was collected from 204 patients with STEMI at hospital admission and before undergoing PCI. Participants were classified as high MMP-9 (n=102) or low MMP-9 (n=102) based on an MMP-9 cut-off of 12.92 ng/ml. Both groups were assessed at one and two years after STEMI.</p><p id="par0030" class="elsevierStylePara elsevierViewall">There was no difference between the high and low MMP-9 groups in terms of baseline or PCI characteristics, but the high MMP-9 group had a significantly higher incidence of cardiopulmonary resuscitation, use of inotropes, cardiogenic shock, intra-aortic balloon pump (IABP) use and no-reflow phenomenon. In-hospital cardiovascular mortality was higher in the high MMP-9 group, but without reaching statistical significance.</p><p id="par0035" class="elsevierStylePara elsevierViewall">When long-term outcomes were analyzed, cardiovascular mortality was significantly higher in the high MMP-9 group at one year (13.7% vs. 4.8% for the low MMP-9 group, p=0.030) and at two years (17.6% vs. 4.9%, p=0.004).</p><p id="par0040" class="elsevierStylePara elsevierViewall">Advanced heart failure was compared between the groups and was significantly more frequent in the high MMP-9 group at two-year follow-up (16.7% vs. 5.9%, p=0.015).</p><p id="par0045" class="elsevierStylePara elsevierViewall">High MMP-9 level was one of the independent predictors of two-year cardiovascular mortality (odds ratio: 3.5; 95% confidence interval: 1.12-11.35), together with age, no-reflow and left ventricular ejection fraction.</p><p id="par0050" class="elsevierStylePara elsevierViewall">An interesting aspect of this study is that the no-reflow phenomenon during the procedure was significantly more frequent in the high MMP-9 group, since no-reflow may lead to cardiogenic shock, inotrope use or the need for IABP, development of advanced heart failure and ultimately cardiovascular mortality.</p><p id="par0055" class="elsevierStylePara elsevierViewall">The authors recognize some limitations of their study. It was a single-center analysis of a relatively small number of patients, and the predictive value of MMP-9 was investigated using 12.92 ng/ml as a cut-off for their cohort, a different value from previous studies, and one that needs validation in other large populations.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Another issue is that all their patients were given clopidogrel rather than ticagrelor or prasugrel, so the precise effect of MMP-9 in MI patients who use newer antiplatelets cannot be determined.</p><p id="par0065" class="elsevierStylePara elsevierViewall">In summary, high MMP-9 levels were an important predictor of major adverse cardiovascular events, including mortality and advanced heart failure, in two-year follow-up in STEMI patients undergoing primary PCI. MMP-9 measurement should therefore be considered as a prognostic marker for STEMI patients.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0070" class="elsevierStylePara elsevierViewall">The author has no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:7 [ 0 => array:3 [ "identificador" => "bib0040" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D.A. Morrow" 1 => "E.M. Antman" 2 => "A. Charlesworth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.cir.102.17.2031" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2000" "volumen" => "102" "paginaInicial" => "2031" "paginaFinal" => "2037" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11044416" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0045" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ProACS risk score: an early and simple score for risk stratification of patients with acute coronary syndromes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Timóteo" 1 => "S. Rosa" 2 => "M. Nogueira" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.repc.2016.05.010" "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2017" "volumen" => "36" "paginaInicial" => "77" "paginaFinal" => "83" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28153630" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0050" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease FRISC Study Group. Fragmin during instability in coronary artery disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B. Lindahl" 1 => "H. Toss" 2 => "A. Siegbahn" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200010193431602" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2000" "volumen" => "343" "paginaInicial" => "1139" "paginaFinal" => "1147" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11036119" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0055" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Blankenberg" 1 => "H.J. Rupprecht" 2 => "O. Poirier" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.CIR.0000058700.41738.12" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2003" "volumen" => "107" "paginaInicial" => "1579" "paginaFinal" => "1585" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12668489" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0060" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "B.J. Jefferis" 1 => "P. Whincup" 2 => "P. Welsh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.atherosclerosis.2009.08.018" "Revista" => array:6 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2010" "volumen" => "208" "paginaInicial" => "557" "paginaFinal" => "563" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19748093" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0065" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Dominguez-Rodriguez" 1 => "P. Abreu-Gonzalez" 2 => "M.J. Garcia-Gonzalez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.atherosclerosis.2006.11.012" "Revista" => array:6 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2008" "volumen" => "196" "paginaInicial" => "365" "paginaFinal" => "371" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17161405" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0070" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The prognostic value of elevated matrix metalloproteinase-9 in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a two-year prospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "M. Somuncu" 1 => "H. Pusuroglu" 2 => "H. Karakurt" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.repc.2020.03.001" "Revista" => array:4 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2020" "volumen" => "39" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32205011" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/08702551/0000003900000005/v2_202006270656/S0870255120302043/v2_202006270656/en/main.assets" "Apartado" => array:4 [ "identificador" => "29261" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Artigos Originais" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/08702551/0000003900000005/v2_202006270656/S0870255120302043/v2_202006270656/en/main.pdf?idApp=UINPBA00004E&text.app=https://www.revportcardiol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255120302043?idApp=UINPBA00004E" ]
Ano/Mês | Html | Total | |
---|---|---|---|
2024 Outubro | 27 | 18 | 45 |
2024 Setembro | 44 | 22 | 66 |
2024 Agosto | 36 | 33 | 69 |
2024 Julho | 40 | 32 | 72 |
2024 Junho | 22 | 15 | 37 |
2024 Maio | 27 | 14 | 41 |
2024 Abril | 29 | 28 | 57 |
2024 Maro | 30 | 23 | 53 |
2024 Fevereiro | 34 | 24 | 58 |
2024 Janeiro | 23 | 22 | 45 |
2023 Dezembro | 32 | 31 | 63 |
2023 Novembro | 31 | 26 | 57 |
2023 Outubro | 28 | 18 | 46 |
2023 Setembro | 21 | 22 | 43 |
2023 Agosto | 24 | 12 | 36 |
2023 Julho | 32 | 7 | 39 |
2023 Junho | 31 | 15 | 46 |
2023 Maio | 27 | 23 | 50 |
2023 Abril | 17 | 5 | 22 |
2023 Maro | 16 | 29 | 45 |
2023 Fevereiro | 12 | 16 | 28 |
2023 Janeiro | 13 | 26 | 39 |
2022 Dezembro | 33 | 19 | 52 |
2022 Novembro | 23 | 22 | 45 |
2022 Outubro | 35 | 25 | 60 |
2022 Setembro | 23 | 39 | 62 |
2022 Agosto | 23 | 27 | 50 |
2022 Julho | 22 | 39 | 61 |
2022 Junho | 28 | 30 | 58 |
2022 Maio | 17 | 40 | 57 |
2022 Abril | 23 | 36 | 59 |
2022 Maro | 40 | 54 | 94 |
2022 Fevereiro | 30 | 32 | 62 |
2022 Janeiro | 21 | 29 | 50 |
2021 Dezembro | 17 | 32 | 49 |
2021 Novembro | 23 | 34 | 57 |
2021 Outubro | 34 | 54 | 88 |
2021 Setembro | 21 | 32 | 53 |
2021 Agosto | 30 | 35 | 65 |
2021 Julho | 23 | 30 | 53 |
2021 Junho | 37 | 22 | 59 |
2021 Maio | 34 | 46 | 80 |
2021 Abril | 24 | 36 | 60 |
2021 Maro | 33 | 28 | 61 |
2021 Fevereiro | 21 | 15 | 36 |
2021 Janeiro | 28 | 27 | 55 |
2020 Dezembro | 25 | 28 | 53 |
2020 Novembro | 17 | 26 | 43 |
2020 Outubro | 15 | 20 | 35 |
2020 Setembro | 31 | 20 | 51 |
2020 Agosto | 17 | 23 | 40 |
2020 Julho | 85 | 54 | 139 |
2020 Junho | 53 | 32 | 85 |